Eli Lilly and Company (LLY) Earnings Date, Estimates & Call Transcripts

$919.91

+6.19 (+0.68%)

(As of 10/9/2024 ET)

Upcoming Earnings Date: Nov. 7Estimated
Actual EPS (Aug. 8): $3.92 Beat By $1.28
Consensus EPS (Aug. 8): $2.64

LLY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LLY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad InvestorPlace

Bigger Than Nvidia?

Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that's all they'll talk about.

Go here now for this breaking story.

Eli Lilly and Company Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	3	$2.34	$2.74	$2.54
Q2 2024	3	$2.41	$2.89	$2.64
Q3 2024	3	$2.93	$4.39	$3.72
Q4 2024	3	$3.04	$5.47	$4.47
FY 2024	12	$10.72	$15.49	$13.37
Q1 2025	1	$4.72	$4.72	$4.72
Q2 2025	1	$5.21	$5.21	$5.21
Q3 2025	1	$6.22	$6.22	$6.22
Q4 2025	1	$7.60	$7.60	$7.60
FY 2025	4	$23.75	$23.75	$23.75
Q1 2026	1	$6.24	$6.24	$6.24
Q2 2026	1	$7.02	$7.02	$7.02
Q3 2026	1	$7.90	$7.90	$7.90

LLY Earnings Date and Information

Eli Lilly and Company last announced its quarterly earnings data on August 8th, 2024. The reported $3.92 EPS for the quarter, topping the consensus estimate of $2.64 by $1.28. The firm earned $11.30 billion during the quarter, compared to the consensus estimate of $9.83 billion. Eli Lilly and Company has generated $6.79 earnings per share over the last year ($6.79 diluted earnings per share) and currently has a price-to-earnings ratio of 135.5. Earnings for Eli Lilly and Company are expected to grow by 45.36% in the coming year, from $16.49 to $23.97 per share. Eli Lilly and Company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off prior year's report dates.

Eli Lilly and Company Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/7/2024 (Estimated)	-	-	-	-	-	-	-
8/8/2024	Q2 2024	$2.64	$3.92	+$1.28	$4.56	$9.83 billion	$11.30 billion
5/6/2024	Q1 2024	$2.53	$2.58	+$0.05	$2.68	$8.94 billion	$8.77 billion
2/6/2024	Q4 2023	$2.30	$2.49	+$0.19	$2.56	$8.95 billion	$9.35 billion
11/2/2023	Q3 2023	($0.08)	$0.10	+$0.18	$0.26	$8.88 billion	$9.50 billion
8/8/2023	Q2 2023	$1.98	$2.11	+$0.13	$2.27	$7.58 billion	$8.31 billion
4/27/2023	Q1 2023	$1.73	$1.62	($0.11)	$1.75	$6.87 billion	$6.96 billion
Get the Latest News and Ratings for LLY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eli Lilly and Company and its competitors with MarketBeat's FREE daily newsletter.
2/2/2023	Q4 2022	$1.83	$2.09	+$0.26	$2.04	$7.39 billion	$7.30 billion
11/1/2022	Q3 2022	$1.97	$1.98	+$0.01	$2.35	$6.91 billion	$6.94 billion
8/4/2022	Q2 2022	$1.80	$1.25	($0.55)	$1.45	$6.85 billion	$6.49 billion
4/28/2022	Q1 2022	$2.32	$2.62	+$0.30	$3.14	$7.29 billion	$7.81 billion
2/3/2022	Q4 2021	$2.51	$2.49	($0.02)	$3.08	$7.89 billion	$8.00 billion
10/25/2021	Q3 2021	$1.98	$1.94	($0.04)	$2.66	$6.64 billion	$6.77 billion
8/2/2021	Q2 2021	$1.89	$1.87	($0.02)	$2.21	$6.59 billion	$6.74 billion
4/26/2021	Q1 2021	$2.12	$1.87	($0.25)	$2.25	$7.10 billion	$6.81 billion
1/28/2021	Q4 2020	$2.35	$2.75	+$0.40	$3.18	$7.27 billion	$7.44 billion
11/1/2020	Q3 2020	$1.71	$1.54	($0.17)	$1.75	$5.87 billion	$5.74 billion
7/30/2020	Q2 2020	$1.58	$1.89	+$0.31	$2.23	$5.77 billion	$5.50 billion
4/23/2020	Q1 2020	$1.48	$1.75	+$0.27	$1.90	$5.48 billion	$5.86 billion
1/30/2020	Q4 2019	$1.52	$1.73	+$0.21	$1.82	$5.92 billion	$6.11 billion
10/23/2019	Q3 2019	$1.43	$1.48	+$0.05	$1.59	$5.50 billion	$5.48 billion

Eli Lilly and Company Earnings - Frequently Asked Questions

When is Eli Lilly and Company's earnings date?: Eli Lilly and Company has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates. Learn more on LLY's earnings history.
What guidance has Eli Lilly and Company issued on next quarter's earnings?: Eli Lilly and Company updated its FY 2024 earnings guidance on Thursday, August, 8th. The company provided EPS guidance of 16.100-16.600 for the period, compared to the consensus estimate of 13.760. The company issued revenue guidance of $45.4 billion-$46.6 billion, compared to the consensus revenue estimate of $43.0 billion.
Did Eli Lilly and Company beat their earnings estimates last quarter?: In the previous quarter, Eli Lilly and Company (NYSE:LLY) reported $3.92 earnings per share (EPS) to beat the analysts' consensus estimate of $2.64 by $1.28. Learn more on analysts' earnings estimate vs. LLY's actual earnings.
How much revenue does Eli Lilly and Company generate each year?: Eli Lilly and Company (NYSE:LLY) has a recorded annual revenue of $38.92 billion.
How much profit does Eli Lilly and Company generate each year?: Eli Lilly and Company (NYSE:LLY) has a recorded net income of $5.24 billion. LLY has generated $6.79 earnings per share over the last four quarters.
What is Eli Lilly and Company's price-to-earnings ratio?: Eli Lilly and Company (NYSE:LLY) has a trailing price-to-earnings ratio of 135.48 and a forward price-to-earnings ratio of 55.79. The price/earnings-to-growth ratio is 2.78.
What is Eli Lilly and Company's EPS forecast for next year?: Eli Lilly and Company's earnings are expected to grow from $16.49 per share to $23.97 per share in the next year, which is a 45.36% increase.